Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
PaperCitations, authors & open-access status
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 374 citations, 2019 year and closed oa status.
374
Citations
2019
Year
closed
OA Status